BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

813 related articles for article (PubMed ID: 25383770)

  • 1. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.
    Williams PL; Marino M; Malee K; Brogly S; Hughes MD; Mofenson LM;
    Pediatrics; 2010 Feb; 125(2):e250-60. PubMed ID: 20083530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.
    Nozyce ML; Huo Y; Williams PL; Kapetanovic S; Hazra R; Nichols S; Hunter S; Smith R; Seage GR; Sirois PA;
    Pediatr Infect Dis J; 2014 Nov; 33(11):1128-33. PubMed ID: 25361407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.
    Brogly SB; Abzug MJ; Watts DH; Cunningham CK; Williams PL; Oleske J; Conway D; Sperling RS; Spiegel H; Van Dyke RB
    Pediatr Infect Dis J; 2010 Aug; 29(8):721-7. PubMed ID: 20539252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
    Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS;
    Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11).
    Sibiude J; Mandelbrot L; Blanche S; Le Chenadec J; Boullag-Bonnet N; Faye A; Dollfus C; Tubiana R; Bonnet D; Lelong N; Khoshnood B; Warszawski J
    PLoS Med; 2014 Apr; 11(4):e1001635. PubMed ID: 24781315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.
    Griner R; Williams PL; Read JS; Seage GR; Crain M; Yogev R; Hazra R; Rich K;
    AIDS Patient Care STDS; 2011 Jul; 25(7):385-94. PubMed ID: 21992592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
    Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants.
    Rice ML; Zeldow B; Siberry GK; Purswani M; Malee K; Hoffman HJ; Frederick T; Buchanan A; Sirois PA; Allison SM; Williams PL;
    Pediatr Infect Dis J; 2013 Oct; 32(10):e406-13. PubMed ID: 24067563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.
    Crain MJ; Williams PL; Griner R; Tassiopoulos K; Read JS; Mofenson LM; Rich KC;
    Pediatr Infect Dis J; 2011 Dec; 30(12):1069-74. PubMed ID: 22051859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
    Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
    AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.
    Spaulding AB; Yu Q; Civitello L; Mussi-Pinhata MM; Pinto J; Gomes IM; Alarcón JO; Siberry GK; Harris DR; Hazra R
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):349-56. PubMed ID: 26879281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.
    Aldrovandi GM; Chu C; Shearer WT; Li D; Walter J; Thompson B; McIntosh K; Foca M; Meyer WA; Ha BF; Rich KC; Moye J
    Pediatrics; 2009 Dec; 124(6):e1189-97. PubMed ID: 19933732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
    Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
    AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals.
    Knapp KM; Brogly SB; Muenz DG; Spiegel HM; Conway DH; Scott GB; Talbot JT; Shapiro DE; Read JS
    Pediatr Infect Dis J; 2012 Feb; 31(2):164-70. PubMed ID: 21983213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children.
    Yao TJ; Malee K; Zhang J; Smith R; Redmond S; Rice ML; Frederick T; Torre P; Mellins CA; Hoffman HJ; Williams PL
    AIDS Patient Care STDS; 2023 Mar; 37(3):119-130. PubMed ID: 36827595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.
    Crowell CS; Williams PL; Yildirim C; Van Dyke RB; Smith R; Chadwick EG; Seage GR; Diperna A; Hazra R;
    AIDS; 2020 Jul; 34(9):1377-1387. PubMed ID: 32310900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.
    Williams PL; Hazra R; Van Dyke RB; Yildirim C; Crain MJ; Seage GR; Civitello L; Ellis A; Butler L; Rich K;
    AIDS; 2016 Jan; 30(1):133-44. PubMed ID: 26731758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.